Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$8.30+0.24 (+2.98%)
Close on Nov 17, 2026Market cap $11.64MP/E –Yield –
Aspire-Lakewood operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Aspire-Lakewood's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.19M. For fiscal 2025 it was -$4.92M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.92M | – |
| FY2024 | Dec 31, 2024 | -$265.19K | – |
| FY2023 | Dec 31, 2023 | -$653.11K | – |
| FY2022 | Dec 31, 2022 | -$1.41M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$927.84K | -293.5% |
| Q3 FY2025 | Sep 30, 2025 | -$1.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.14M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.75M | – |
| Q4 FY2024 | Dec 31, 2024 | $479.57K | – |
| Q3 FY2024 | Sep 30, 2024 | -$495.54K | – |
| Q2 FY2024 | Jun 30, 2024 | -$56.24K | – |
| Q1 FY2024 | Mar 31, 2024 | -$192.97K | – |
| Q4 FY2023 | Dec 31, 2023 | -$156.13K | – |
| Q3 FY2023 | Sep 30, 2023 | -$124.92K | – |
| Q2 FY2023 | Jun 30, 2023 | -$189.95K | – |
| Q1 FY2023 | Mar 31, 2023 | -$182.11K | – |
| Q4 FY2022 | Dec 31, 2022 | -$35.87K | – |
| Q3 FY2022 | Sep 30, 2022 | -$46.62K | – |
| Q2 FY2022 | Jun 30, 2022 | -$38.37K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.29M | – |
See a number that looks wrong?